Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.51 -0.01 (-0.22%) Market Cap: 720.42 Mil Enterprise Value: 1.26 Bil PE Ratio: 112.75 PB Ratio: 0 GF Score: 55/100

Ironwood Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 08:35PM GMT
Release Date Price: $10.97 (+7.44%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. My name is Balaji Prasad. I lead the specialty pharma coverage for Barclays. Thank you for dialing into the Barclays Global Healthcare Conference. We're continuing on with the specialty pharma track of conference. And I'm pleased to introduce the management of Ironwood to you. So we have with us Tom McCourt, President and CEO; and Gina Consylman, Senior Vice President and CFO.

Tom and Gina, thank you for taking your time to speak to us. And the format for today would be a presentation session followed by fireside. So I'll hand it over to you, Tom for the presentation.

Thomas A. McCourt
Ironwood Pharmaceuticals, Inc. - President

Thanks, Balaji. And on behalf of Gina and I, and the entire management team at Ironwood, I want to thank Barclays for the opportunity to participate in the conference. We had an extremely productive day today, with some terrific conversations and is very insightful and we learned an awful lot. So thanks again for providing us this forum

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot